Venturis Therapeutics' long-time counsel quitting on the company in April 2021 because the company owes the law firm, Dentons (one of the largest in the country) a sum in excess of $200,000 is a disaster. AND, Dentons has said the company has no assets or income stream from which to pay what is owed. That puts to rest all the anonymous nonsense about how valuable the Venturis patents are. They're not, and anyone who knows the first thing about biotech can see that clearly.
Dentons quitting is a big, big deal. It is confirmation from Venturis's own counsel that this company is hopeless. If they thought there was any money that could be collected, I'm sure they would have tried to collect. According to partner Barry Canaday, there is nothing of value at Venturis.
This thing is going to be liquidated soon in my opinion.
